Biochemical and Biophysical Research Communications, Vol.377, No.1, 280-285, 2008
Protein tyrosine kinase p56(lck)-deficiency confers hypersusceptibility to rho-fluorophenylalanine (pFPhe)-induced apoptosis by augmenting mitochondrial apoptotic pathway in human Jurkat T cells
Phenylalanine analog, rho-fluorophenylalanine (pFPhe)-mediated cytotoxicity and several apoptotic events including mitochondrial cytochrome c release, activation of caspase-9, -3, and -8, Bid cleavage, degradation of PARP and PLC gamma-1, and DNA fragmentation were more significant in p56(lck)-deficient Jurkat T cells (JCaM 1.6) than in wild-type Jurkat T cells (E6.1). The susceptibility of JCaM 1.6 toward apoptogenic activity of pFPhe decreased after acquisition of p561(lck) by transfection. The p56(lck) kinase activity increased 1.6-fold at 15-30 min after pFPhe treatment. The pan-caspase inhibitor (z-VAD-fmk) completely blocked the pFPhe-mediated apoptotic changes except caspase-9 activation. The caspase-8 inhibitor (z-IETD-fmk), which failed to influence pFPhe-induced caspase-9 activation, completely blocked caspase-8 activation and PLC gamma-1 degradation with a marked reduction in caspase-3 activation and PARP degradation, indicating pFPhe-induced caspase-8 activation as a downstream event of mitochondria-dependent activation of caspase-9. These results indicate that the deficiency of p56(lck) augments pFPhe-induced mitochondrial cytochrome c release and resultant apoptotic cell death in Jurkat T cells. (C) 2008 Elsevier Inc. All rights reserved.
Keywords:rho-Fluorophenylalanine;Phenylalanine analog;Apoptosis;Mitochondrial cytochrome c release;Caspase cascade;p56(lck)-dificiency;p56(lck) kinase